Product Introduction:
Trivolib Forte Tablet is a triple combination anti-diabetic medication containing Voglibose (0.3 mg), Metformin (500 mg), and Glimepiride (2 mg). This combination helps control post-meal and fasting blood glucose levels in patients with type 2 diabetes mellitus by improving insulin sensitivity, increasing insulin secretion, and slowing down carbohydrate absorption.
Uses:
-
Type 2 Diabetes Mellitus
-
Poorly controlled blood sugar despite single or dual therapy
-
Management of postprandial and fasting hyperglycemia
Benefits:
-
Provides better glycemic control with triple action
-
Reduces risk of diabetes-related complications
-
Targets both fasting and post-meal sugar spikes
-
Suitable for long-term diabetes management
Composition:
-
Voglibose – 0.3 mg
-
Metformin Hydrochloride – 500 mg
-
Glimepiride – 2 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Nausea, vomiting, or diarrhea
-
Stomach discomfort
-
Flatulence or bloating
-
Dizziness or headache
Safety Advice:
-
Take the tablet with food to minimize stomach upset and hypoglycemia risk
-
Monitor blood sugar levels regularly
-
Not recommended in patients with severe kidney or liver disease
-
Avoid alcohol as it increases the risk of lactic acidosis
-
Store in a cool, dry place away from direct sunlight
-
Keep out of reach of children
